Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Nov;14(11):651-7.
doi: 10.1046/j.1525-1497.1999.01049.x.

Direct-to-consumer prescription drug advertising and the public

R A Bell  1 , R L Kravitz, M S Wilkes
Affiliations

Direct-to-consumer prescription drug advertising and the public

R A Bell et al. J Gen Intern Med. 1999 Nov.

Abstract

Objective: Drug manufacturers are intensely promoting their products directly to consumers, but the impact has not been widely studied. Consumers' awareness and understanding of, attitudes toward, and susceptibility to direct-to-consumer (DTC) drug advertising were examined.

Design: Random-digit dialing telephone survey with a random household member selection procedure (completion and response rates, 58% and 69%, respectively).

Setting: Respondents were interviewed while they were at their residences.

Participants: Complete data were obtained from 329 adults in Sacramento County, California.

Measurements and main results: Outcome measures included awareness of advertisements for 10 selected drugs, misconceptions about DTC advertising, attitudes toward DTC ads, and behavioral responses to such promotions. The influence of demographic characteristics, health status, attitudes, beliefs, and media exposure on awareness and behaviors was examined. On average, respondents were aware of advertisements for 3.7 of the 10 drugs; awareness varied from 8% for Buspar (buspirone) to 72% for Claritin (loratadine). Awareness was associated with prescription drug use, media exposure, positive attitudes toward DTC advertising, poorer health, and insurance status. Substantial misconceptions were revealed; e.g., 43% thought that only "completely safe" drugs could be advertised. Direct-to-consumer advertisements had led one third of respondents to ask their physicians for drug information and one fifth to request a prescription.

Conclusions: Direct-to-consumer advertisements are reaching the public, but selectively so, and affecting their behaviors. Implications for public policy are examined.

PubMed Disclaimer

Comment in

  • Let (us help) the consumer beware!
    Sauder R. Sauder R. J Gen Intern Med. 1999 Nov;14(11):705-6. doi: 10.1046/j.1525-1497.1999.14002.x. J Gen Intern Med. 1999. PMID: 10571720 Free PMC article. No abstract available.

References

    1. Mueller C, Schur C, O'Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health. 1997;87:1626–9. - PMC - PubMed
    1. Giaquinta D. Drug formularies—good or evil? A view from a managed care provider. Cardiology. 1994;85(suppl 1):30–5. - PubMed
    1. Jaklevic MC. Prescribed cutback: HMOs shift risk to doc groups to curb drug utilization. Mod Healthcare. 1997;27(29):34. - PubMed
    1. Growth seen in ads for direct-to-consumer drugs. Am Med News. April 27 1998;16
    1. ‘ t Hoen E. Direct-to-consumer advertising: for better profits or for better health? Am J Health-System Pharmacy. 1998;55:594–7. - PubMed